Literature DB >> 8216316

Metformin increases glucose transporter protein and gene expression in human fibroblasts.

A Hamann1, H Benecke, H Greten, S Matthaei.   

Abstract

To investigate the effect of the antihyperglycemic drug metformin on glucose transporter protein and gene expression, skin fibroblasts obtained from normal and diabetic volunteers were grown in culture and incubated with metformin at various concentration for up to 16 days. Metformin caused a dose and time dependent increase in GLUT1 number with a maximum at a concentration of 10 micrograms metformin given over 4 days. This was accompanied by an increase in GLUT1 mRNA, suggesting that metformin has a stimulating effect on glucose transporter gene expression. No significant difference was observed between cells obtained from type II diabetic patients and those from controls. We conclude that in human fibroblasts GLUT1 de novo synthesis is involved in the long term effect of metformin on glucose transport.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8216316     DOI: 10.1006/bbrc.1993.2260

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.

Authors:  M R Owen; E Doran; A P Halestrap
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

Review 2.  A risk-benefit assessment of metformin in type 2 diabetes mellitus.

Authors:  H C Howlett; C J Bailey
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

3.  Acute exacerbation of interstitial lung disease with lung cancer after surgery: evaluation with 2-[18]-fluoro-2-deoxy-D-glucose positron emission tomography.

Authors:  Tomohiro Maniwa; Masahiro Endo; Mitsuhiro Isaka; Kazuo Nakagawa; Yasuhisa Ohde; Takehiro Okumura; Haruhiko Kondo
Journal:  Surg Today       Date:  2013-09-05       Impact factor: 2.549

Review 4.  Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.

Authors:  C J Dunn; D H Peters
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

5.  Screening Novel Molecular Targets of Metformin in Breast Cancer by Proteomic Approach.

Authors:  Lobna Al-Zaidan; Rasha Abu El Ruz; Ahmed M Malki
Journal:  Front Public Health       Date:  2017-10-16

6.  Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal Origin.

Authors:  Corinna Seliger; Anne-Louise Meyer; Verena Leidgens; Lisa Rauer; Sylvia Moeckel; Birgit Jachnik; Judith Proske; Katja Dettmer; Tanja Rothhammer-Hampl; Leon D Kaulen; Markus J Riemenschneider; Peter J Oefner; Marina Kreutz; Nils-Ole Schmidt; Marsha Merrill; Martin Uhl; Kathrin Renner; Arabel Vollmann-Zwerenz; Martin Proescholdt; Peter Hau
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.